Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

4 Résultats
authFullName_s : Simon Pernot
Image document

FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer

Violaine Randrian , Simon Pernot , Karine Le Malicot , Vittorio Catena , Isabelle Baumgaertner et al.
Digestive and Liver Disease, 2022, 54 (7), pp.857-863. ⟨10.1016/j.dld.2022.04.024⟩
Article dans une revue hal-03906999v1

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stefano Kim , Eric François , Thierry André , Emmanuelle Samalin , Marine Jary et al.
Lancet Oncology, 2018, 19 (8), pp.1094 - 1106. ⟨10.1016/S1470-2045(18)30321-8⟩
Article dans une revue hal-01863908v1

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

Simon Pernot , Cecile Badoual , Magali Terme , Florence Castan , Aurelie Cazes et al.
European Journal of Cancer, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
Article dans une revue hal-01579145v1

Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)

Alexandra Lapeyre-Prost , Simon Pernot , Julie Sigrand , Karine Le Malicot , Florence Mary et al.
Clinical Colorectal Cancer, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Article dans une revue hal-03284418v1